Clinical Trials

130 enrolled

Locally Advanced Rectal Cancer

NCT06787183 2026-03-03

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

42 enrolled

Locally Advanced Rectal Cancer With Liver Metastases

NCT07331428 2026-01-09

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

25 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06333769 2025-08-15

Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer

Phase 2 Completed

38 enrolled

Phase 2 Active not recruiting

Mid-low Rectal Cancer

NCT04864067 2025-07-01

NOAHS-ARC

73 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT06888843 2025-03-27

AHTCRR-1

160 enrolled

Colorectal Neoplasms

NCT06788171 2025-01-23

PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM

35 enrolled

Colorectal Cancer Liver Metastasis

NCT06598046 2024-09-19

A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

48 enrolled

Breast Neoplasms

NCT06176534 2024-08-20

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

240 enrolled

Advanced Breast Cancer

NCT06490913 2024-07-08

Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

33 enrolled

Liver Metastases of Colorectal Cancer

NCT06475443 2024-06-26

Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs

32 enrolled

Metastatic Breast Cancer in the Brain

NCT06331845 2024-03-26

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Phase 2 Active not recruiting

39 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03950271 2024-02-28

SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma

25 enrolled

Phase 2 Active not recruiting

Stomach Neoplasms

NCT03756298 2023-11-09

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

284 enrolled

Triple Negative Breast Neoplasms

NCT03691051 2023-09-25

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

78 enrolled

HER2 Positive Metastatic Breast Cancer

NCT05479240 2023-06-18

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

94 enrolled

Immunotherapy

NCT05207735 2022-01-26

SCRCA

73 enrolled

Cholangiocarcinoma

NCT00640081 2021-09-22

Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

Phase 2 Completed

169 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04220528 2020-01-07

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

129 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01952951 2017-09-13

PREPARE

110 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT01843829 2014-03-24

NeoSCOPE

85 enrolled

Esophageal Neoplasms

NCT00658840 2012-04-03

Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma

55 enrolled

Pancreatic Neoplasms

NCT01331928 2011-04-08

Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer

51 enrolled

Stomach Neoplasms

NCT00453323 2010-07-12

Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer

33 enrolled

Esophageal Neoplasms

NCT00580359 2008-01-08

S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer

96 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT00506168 2007-07-25

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

Phase 2 Terminated

37 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00506844 2007-07-25

ERBIRIX

40 enrolled